7 Amino Heptanoic Acid Sales

Amino Heptanoic Acid Sales Market Outlook

The global amino heptanoic acid market is anticipated to reach approximately USD 500 million by 2035, progressing at a compound annual growth rate (CAGR) of about 5.2% during the forecast period from 2025 to 2035. The growing demand for amino acids in various industries, notably pharmaceuticals and nutraceuticals, is driving this market's growth. Additionally, the rising awareness of the health benefits associated with amino acids, such as improved metabolic functions and muscle recovery, is further propelling the market forward. The increasing utilization of amino heptanoic acid in food additives and its potential role in enhancing the nutritional value of food products are also contributing factors to market expansion. Furthermore, advancements in production techniques and a shift towards synthetic production processes are enhancing availability and reducing costs, thereby stimulating demand across various sectors.

Growth Factor of the Market

The amino heptanoic acid market is poised for significant growth, primarily driven by the increasing applications of amino acids in pharmaceuticals and nutraceuticals. As health consciousness rises globally, the demand for dietary supplements that incorporate amino heptanoic acid is expected to soar, particularly among athletes and fitness enthusiasts seeking enhanced performance and recovery. The pharmaceutical industry is also evolving, with amino heptanoic acid showing potential in therapeutic applications, thereby expanding its market footprint. Moreover, the burgeoning food industry, focused on health-driven products, is contributing to the demand for amino heptanoic acid as an essential ingredient in various food additives. Innovations in product formulations and the growing trend of personalized nutrition are expected to further bolster market growth, creating new opportunities for manufacturers and suppliers alike.

Key Highlights of the Market

• The market is projected to achieve a size of USD 500 million by 2035.
• Compound annual growth rate (CAGR) of 5.2% is anticipated during the forecast period.
• Increased applications in pharmaceuticals and nutraceuticals are key growth drivers.
• Rising health consciousness among consumers boosts demand for dietary supplements.
• Innovative product formulations and personalized nutrition trends are creating new opportunities.

By Product Type

L-Form:

The L-form of amino heptanoic acid is predominantly used in various health and wellness applications, especially in the pharmaceutical sector. Its importance is underscored by its role in protein synthesis and neurotransmitter function, making it a critical ingredient for dietary supplements. The L-form is favored for its bioavailability and effectiveness in promoting muscle recovery and growth, which is particularly relevant in sports nutrition. The growing trend of fitness and health awareness is fostering the demand for L-form amino heptanoic acid, leading to a robust market segment. Manufacturing advancements further enhance its availability, making it accessible to a broader audience.

D-Form:

D-Form amino heptanoic acid is less common than its L-counterpart but still plays a vital role in niche applications. Its unique properties make it suitable for specific pharmaceutical formulations and research applications. The D-form is often utilized in experimental setups and studies exploring the effects of amino acids on metabolism and behavior. The increasing focus on scientific research and innovation in the pharmaceutical industry is expected to gradually amplify the demand for D-form amino heptanoic acid as researchers explore its potential benefits. This segment, although smaller, holds significant importance due to its specialized applications and research relevance.

DL-Form:

The DL-form of amino heptanoic acid, which combines both the L- and D-forms, serves multiple purposes in various industries. It is often used in nutritional products due to its balanced amino acid profile, appealing to a wide range of consumers. This form is especially popular in dietary supplements aimed at improving overall health and wellness. The versatility of DL-form amino heptanoic acid in applications ranging from food additives to pharmaceuticals enhances its market demand. As consumers increasingly seek products that offer comprehensive health benefits, the DL-form is likely to gain traction within the market, driven by the growing popularity of all-in-one supplements.

Natural Form:

The natural form of amino heptanoic acid is derived from natural sources and is gaining popularity among health-conscious consumers who prefer organic and clean-label products. With the increasing demand for natural ingredients in food and dietary supplements, manufacturers are focusing on sourcing amino heptanoic acid from natural sources, such as plant-based materials. This shift aligns with the broader trend of sustainability and health awareness, further driving the segment's growth. The natural form is often marketed as having superior bioavailability and health benefits, enhancing its appeal to consumers seeking alternatives to synthetic ingredients.

Synthetic Form:

The synthetic form of amino heptanoic acid has been widely adopted due to its cost-effectiveness and scalability in production. As manufacturers look to meet the rising demand across various industries, synthetic amino heptanoic acid offers a reliable and consistent supply. This form is predominantly used in pharmaceuticals and industrial applications, where precise formulation is critical. With ongoing advancements in synthetic production techniques, the quality and purity of synthetic amino heptanoic acid are continuously improving, making it a preferred choice for many applications. The synthetic segment is expected to thrive as industries increasingly rely on efficient and sustainable sourcing.

By Application

Pharmaceuticals:

The pharmaceutical industry is one of the largest consumers of amino heptanoic acid, utilizing it in various formulations for its therapeutic benefits. This segment includes applications in drug development, where amino heptanoic acid plays a role in enhancing drug efficacy and bioavailability. The growing focus on developing new therapeutic agents, particularly those targeting metabolic disorders and neurological conditions, is driving the demand for amino heptanoic acid in pharmaceuticals. Additionally, with increasing research and development activities in the pharmaceutical sector, the demand for this compound is projected to witness significant growth.

Nutraceuticals:

Amino heptanoic acid is increasingly incorporated into nutraceuticals, as consumers seek supplements that support overall health and fitness. This segment is experiencing robust growth due to a rising trend in preventive healthcare and a greater emphasis on maintaining a healthy lifestyle. Nutraceuticals containing amino heptanoic acid are marketed for their benefits in muscle recovery, energy production, and immune function. The expanding market for dietary supplements, coupled with growing awareness of the importance of amino acids in nutrition, is expected to further propel this segment. This growth is supported by an increase in consumer spending on health and wellness products.

Food Additives:

The incorporation of amino heptanoic acid in food additives is on the rise, driven by the increasing demand for functional and health-oriented food products. As consumers become more health-conscious, food manufacturers are seeking ways to enhance the nutritional profile of their products. Amino heptanoic acid is used as an ingredient in various food applications to improve flavor, texture, and nutritional value. The growing trend of fortified foods and beverages is expected to contribute to the expansion of this segment, as manufacturers aim to cater to the evolving preferences of health-conscious consumers.

Industrial:

In the industrial sector, amino heptanoic acid is utilized for its chemical properties, particularly in the production of specialty chemicals and polymers. The versatility of amino heptanoic acid makes it valuable in various industrial applications, including coatings, adhesives, and agricultural products. As industries continue to seek innovative solutions that enhance product performance and sustainability, the demand for amino heptanoic acid in industrial applications is expected to grow. The increasing focus on eco-friendly production methods and the development of bio-based products are likely to further boost this segment's growth prospects.

By Distribution Channel

Online Stores:

Online stores have become a significant distribution channel for amino heptanoic acid products, providing convenience and accessibility to consumers. With the rise of e-commerce, customers are increasingly turning to online platforms to purchase dietary supplements and pharmaceuticals, enjoying the ease of comparison shopping and home delivery. This channel is particularly appealing to the health-conscious demographic, which frequently seeks information about products and prefers purchasing from reputable online retailers. As more consumers embrace digital shopping, the online distribution channel is expected to continue expanding rapidly, driving overall market growth.

Specialty Stores:

Specialty stores play a crucial role in the distribution of amino heptanoic acid products, particularly in the health and wellness sector. These stores cater to consumers looking for specific health products, including dietary supplements and functional foods. The presence of knowledgeable staff and the ability to offer a curated selection of products make specialty stores a favored destination for consumers seeking high-quality amino heptanoic acid supplements. The growing trend of personalized nutrition and wellness solutions is likely to enhance the popularity of specialty stores, as they can provide tailored advice and recommendations to customers.

Direct Sales:

Direct sales channels allow manufacturers to reach consumers without intermediaries, fostering relationships and enhancing brand loyalty. This model has gained traction in the amino heptanoic acid market, as companies leverage direct-to-consumer strategies to offer personalized services and exclusive products. Direct sales often involve online platforms, allowing companies to provide detailed product information and promote health benefits effectively. The advantages of this channel, including better profit margins and increased consumer engagement, are pushing more companies to adopt direct sales approaches, resulting in significant growth in this segment.

Distributors:

Distributors serve as an essential link between manufacturers and retailers in the amino heptanoic acid market. By managing the logistics and warehousing of products, distributors ensure a smooth supply chain, which is vital for meeting the growing demand from various sectors. The role of distributors is particularly important in ensuring that smaller retailers have access to a wide range of amino heptanoic acid products. As the market continues to evolve, distributors are adapting by offering additional services such as marketing support and product education to help their retail partners succeed.

Wholesalers:

Wholesalers provide a valuable distribution channel for amino heptanoic acid by bulk-buying products from manufacturers and selling them to retailers. This channel is significant in managing inventory and costs effectively, helping to drive down prices for end consumers. The wholesale segment allows retailers to stock a variety of products without significant upfront investments. As the demand for amino heptanoic acid products continues to surge across different applications, wholesalers are poised to play a crucial role in ensuring that these products are readily available in various markets, thereby enhancing market access for both retailers and consumers.

By Ingredient Type

Pure Amino Heptanoic Acid:

Pure amino heptanoic acid is highly sought after in various applications, particularly in the pharmaceutical and nutraceutical industries. Its high purity ensures optimal efficacy and bioavailability for consumers seeking health benefits associated with amino acids. The demand for pure forms of amino heptanoic acid is driven by the increasing focus on product quality and safety, as consumers become more discerning about the ingredients in their dietary supplements and pharmaceuticals. This trend is likely to fuel the growth of the pure ingredient segment, as manufacturers respond to consumer preferences for high-quality and effective products.

Amino Heptanoic Acid Blends:

Amino heptanoic acid blends are formulated to offer a balanced profile of amino acids, catering to the diverse needs of consumers. These blends are particularly popular in the sports nutrition market, where a combination of amino acids can enhance muscle recovery and performance. The growing interest in personalized nutrition is driving the trend toward customized blends that target specific health and fitness goals. As consumers seek optimized formulations that provide comprehensive benefits, the segment of amino heptanoic acid blends is expected to experience substantial growth, capturing the attention of manufacturers and product developers alike.

Amino Heptanoic Acid Derivatives:

Amino heptanoic acid derivatives are emerging as a significant segment within the market, as they offer unique properties and applications in various fields. These derivatives are often utilized in specialized formulations, such as pharmaceuticals, where they can enhance therapeutic effects or improve product stability. The versatility of amino heptanoic acid derivatives makes them valuable in research and industrial applications as well. As the focus on innovation and product development in the amino acid sector continues to rise, the derivatives segment is likely to see increased investment and growth opportunities, driven by advancements in analytical techniques and formulation science.

Others:

The "others" category encompasses various alternative formulations and applications of amino heptanoic acid that do not fit neatly into the previous segments. This could include niche products and emerging applications that are gaining traction in specific markets. As the amino heptanoic acid market evolves, it is likely that new ingredient types and innovative applications will emerge, reflecting changing consumer preferences and technological advancements. The diversity within the "others" segment presents opportunities for manufacturers to explore and develop unique products that cater to untapped market needs.

By Region

The North American amino heptanoic acid market is expected to dominate the global scene, accounting for approximately 35% of the total market share by 2035. This region's leadership can be attributed to a well-established pharmaceutical and nutraceutical industry, along with a growing consumer base that emphasizes fitness and health. The United States and Canada are witnessing increased investments in R&D and production, which are enhancing the availability of high-quality amino heptanoic acid products. Additionally, the rising trend of dietary supplements among athletes and fitness enthusiasts is fueling market growth. The CAGR for the North American market is projected to be around 5.5%, indicating steady growth over the forecast period.

In Europe, the amino heptanoic acid market is poised for significant growth, with an expected market share of 30% by 2035. The increasing focus on health and wellness among European consumers is driving the demand for amino acid-based dietary supplements and functional foods. The region's stringent regulations and high safety standards are prompting manufacturers to invest in high-purity products, particularly in the pharmaceutical sector. Countries such as Germany, the UK, and France are leading the charge in market growth, supported by rising health awareness and increasing consumer spending on nutraceutical products. Furthermore, the CAGR for the European market is anticipated to be around 4.8%, reflecting a robust outlook for the coming years.

Opportunities

The amino heptanoic acid market is witnessing numerous opportunities, particularly driven by the growing demand for health supplements and functional foods. With increasing consumer awareness regarding the importance of amino acids for overall well-being, manufacturers have a chance to innovate and expand their product portfolios to include amino heptanoic acid in various formulations. This trend presents opportunities to create specialized products tailored to specific health benefits, such as muscle recovery, cognitive function, and metabolic health. Additionally, as the trend toward personalized nutrition continues to rise, companies have an opportunity to develop customized blends of amino heptanoic acid that cater to individual consumer needs, unlocking new revenue streams in the process.

Another significant opportunity lies in the expansion of e-commerce platforms for amino heptanoic acid products. As online shopping continues to gain traction, manufacturers and suppliers can leverage digital channels to reach a broader audience and cater to health-conscious consumers seeking convenience. By adopting effective online marketing strategies and engaging consumers through social media platforms, companies can create brand loyalty and increase sales. Furthermore, collaborations with health influencers and nutritionists can help enhance product visibility and credibility, ultimately driving growth in this segment. The evolving landscape of distribution channels presents an excellent opportunity for the amino heptanoic acid market to flourish in the coming years.

Threats

The amino heptanoic acid market faces several threats that could hinder its growth trajectory. One of the most prominent challenges is the increasing competition from alternative amino acids and supplements that are gaining popularity among consumers. As new products enter the market, they could divert consumer attention and spending away from amino heptanoic acid, particularly if they are marketed more effectively or priced competitively. Furthermore, fluctuations in raw material prices can impact production costs, potentially leading to increased prices for end consumers and affecting overall demand. Manufacturers must remain vigilant and responsive to market dynamics to mitigate these threats and sustain growth.

Another significant restrainer for the amino heptanoic acid market is the regulatory landscape surrounding dietary supplements and food additives. Stricter regulations imposed by government bodies can increase compliance costs for manufacturers, impacting their profitability and ability to innovate. Additionally, consumers are becoming more cautious about product safety and efficacy, necessitating that companies invest in rigorous testing and transparency regarding their products. Failure to adhere to these regulatory requirements can result in product recalls, tarnishing brand reputation and consumer trust. As a result, manufacturers must navigate these challenges carefully and ensure compliance to maintain a competitive edge in the market.

Competitor Outlook

• Ajinomoto Co., Inc.
• Evonik Industries AG
• Kyowa Hakko Bio Co., Ltd.
• Fufeng Group Company Limited
• Jiangsu Ajinomoto Co., Ltd.
• Ginkgo BioWorks
• NutraBlend Foods, LLC
• Shanghai Deda Pharmaceutical Co., Ltd.
• Vitahealth (M) Sdn. Bhd.
• Hubei Yanbian Chemical Co., Ltd.
• Merck Group
• DAIICHI SANKYO COMPANY, LIMITED
• Sojitz Corporation
• Hunan Huasheng Pharmaceutical Co., Ltd.
• AB BIOPRODUCTS LTD.

The competitive landscape of the amino heptanoic acid market is characterized by a mix of established players and emerging companies, all vying for market share in a growing industry. Major companies such as Ajinomoto Co., Inc. and Evonik Industries AG dominate the market, leveraging their extensive experience in amino acid production and strong distribution networks to maintain their competitive advantage. These companies invest significantly in research and development to innovate and expand their product offerings, catering to the evolving needs of consumers in pharmaceuticals, nutraceuticals, and food sectors. The intense competition drives innovation, leading to the introduction of new formulations and blends, further enriching the market landscape.

Additionally, the emergence of smaller players and start-ups in the amino heptanoic acid sector adds a layer of competitiveness. These companies often focus on niche applications or innovative formulations to differentiate themselves from established brands. The rise of health-conscious consumers seeking specialized nutritional solutions creates opportunities for these new entrants to capture market share. Collaborations and partnerships between established companies and emerging companies can facilitate knowledge exchange and drive innovation, benefiting both parties. The competitive dynamics in this market will likely continue to evolve as consumer preferences shift and new technologies disrupt traditional manufacturing and distribution methods.

Key companies such as Kyowa Hakko Bio Co., Ltd. and Fufeng Group Company Limited are focusing on expanding their production capacities and enhancing their supply chains to meet the increasing global demand for amino heptanoic acid. These companies emphasize sustainability and environmentally friendly practices in their production processes, aligning with the growing trend of eco-conscious consumption. Furthermore, their involvement in research initiatives and collaborations with academic institutions enables them to stay ahead of the curve in terms of product development and market trends. This proactive approach positions them favorably in the competitive landscape, allowing them to adapt quickly to changing market dynamics and consumer needs.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 Merck Group
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 Ginkgo BioWorks
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 Sojitz Corporation
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 AB BIOPRODUCTS LTD.
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 Ajinomoto Co., Inc.
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 Evonik Industries AG
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 NutraBlend Foods, LLC
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 Vitahealth (M) Sdn. Bhd.
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 Kyowa Hakko Bio Co., Ltd.
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 Jiangsu Ajinomoto Co., Ltd.
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 Fufeng Group Company Limited
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 DAIICHI SANKYO COMPANY, LIMITED
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 Hubei Yanbian Chemical Co., Ltd.
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 Shanghai Deda Pharmaceutical Co., Ltd.
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 Hunan Huasheng Pharmaceutical Co., Ltd.
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 7 Amino Heptanoic Acid Sales Market, By Application
    • 6.1.1 Pharmaceuticals
    • 6.1.2 Nutraceuticals
    • 6.1.3 Food Additives
    • 6.1.4 Industrial
  • 6.2 7 Amino Heptanoic Acid Sales Market, By Ingredient Type
    • 6.2.1 Pure Amino Heptanoic Acid
    • 6.2.2 Amino Heptanoic Acid Blends
    • 6.2.3 Amino Heptanoic Acid Derivatives
    • 6.2.4 Others
  • 6.3 7 Amino Heptanoic Acid Sales Market, By Distribution Channel
    • 6.3.1 Online Stores
    • 6.3.2 Specialty Stores
    • 6.3.3 Direct Sales
    • 6.3.4 Distributors
    • 6.3.5 Wholesalers

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Middle East & Africa - Market Analysis
    • 10.5.1 By Country
      • 10.5.1.1 Middle East
      • 10.5.1.2 Africa
  • 10.6 7 Amino Heptanoic Acid Sales Market by Region

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global 7 Amino Heptanoic Acid Sales market is categorized based on

By Application

• Pharmaceuticals
• Nutraceuticals
• Food Additives
• Industrial

By Distribution Channel

• Online Stores
• Specialty Stores
• Direct Sales
• Distributors
• Wholesalers

By Ingredient Type

• Pure Amino Heptanoic Acid
• Amino Heptanoic Acid Blends
• Amino Heptanoic Acid Derivatives
• Others

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• Ajinomoto Co., Inc.
• Evonik Industries AG
• Kyowa Hakko Bio Co., Ltd.
• Fufeng Group Company Limited
• Jiangsu Ajinomoto Co., Ltd.
• Ginkgo BioWorks
• NutraBlend Foods, LLC
• Shanghai Deda Pharmaceutical Co., Ltd.
• Vitahealth (M) Sdn. Bhd.
• Hubei Yanbian Chemical Co., Ltd.
• Merck Group
• DAIICHI SANKYO COMPANY, LIMITED
• Sojitz Corporation
• Hunan Huasheng Pharmaceutical Co., Ltd.
• AB BIOPRODUCTS LTD.